Group 6 Copy 557
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Modeling Zika virus transmission from mother to child using uterine mini-organs

    As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...

    Manuka Honey: A New Tool in the Battle Against Antibiotic Resistance?

    Since settlers brought honeybees to New Zealand, inhabitants have utilized honey produced from the native...

    Finding a Cure for Batten Disease

    In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

    Backer Badge Funded